Relay Therapeutics, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a RLAY research report →
Companywww.relaytx.com
Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications.
- CEO
- Sanjiv K. Patel
- IPO
- 2020
- Employees
- 259
- HQ
- Cambridge, MA, US
Price Chart
Valuation
- Market Cap
- $2.49B
- P/E
- -8.59
- P/S
- 233.63
- P/B
- 3.65
- EV/EBITDA
- -7.97
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 89.67%
- Op Margin
- -2776.61%
- Net Margin
- -2554.14%
- ROE
- -43.94%
- ROIC
- -44.00%
Growth & Income
- Revenue
- $15.36M · 53.44%
- Net Income
- $-276,479,000 · 18.13%
- EPS
- $-1.61 · 31.78%
- Op Income
- $-302,738,000
- FCF YoY
- 6.08%
Performance & Tape
- 52W High
- $17.32
- 52W Low
- $2.75
- 50D MA
- $12.62
- 200D MA
- $8.17
- Beta
- 1.75
- Avg Volume
- 3.30M
Get TickerSpark's AI analysis on RLAY
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 14, 26 | Catinazzo Thomas | sell | 17,717 |
| Apr 28, 26 | Catinazzo Thomas | sell | 972 |
| Apr 28, 26 | Rahmer Peter | sell | 753 |
| Apr 28, 26 | Bergstrom Donald A | sell | 1,490 |
| Apr 9, 26 | Catinazzo Thomas | other | 1,800 |
| Apr 7, 26 | Catinazzo Thomas | sell | 17,717 |
| Apr 9, 26 | Catinazzo Thomas | sell | 1,800 |
| Apr 9, 26 | Catinazzo Thomas | other | 1,800 |
| Mar 9, 26 | Catinazzo Thomas | sell | 17,717 |
| Jan 27, 26 | Bergstrom Donald A | sell | 18,895 |
Our RLAY Coverage
We haven't published any research on RLAY yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate RLAY Report →